90/016,420DEPOT SYSTEMS COMPRISING CARIPRAZINE OR SALTS THEREOF11,931,357Open

Status

Determination - Reexamination Ordered

Filed

Jun 26, 2026

Pre-Order Paper

Filed Jul 24, 2026

Requester reply Aug 4, 2026

Last Updated

Sep 3, 2026

Art Unit

3991

Requester

Anonymous

Requester Law Firm

MagStone Law, LLP

Requested By

Third Party

Patent Owner(via USPTO assignment records)

Mapi Pharma Ltd.

Patent Owner Law Firm

MagStone Law, LLP

Sector (CPC)

ALife Sciences & Consumer
A61Medical & Pharmaceutical
A61KPharmaceutical Preparations

USPC

514Drug, Bio-Affecting And Body Treating Compositions

Reexam History (31 events)

Sep 14, 2026RXPTDIReexam Petition Decision - Dismissed
Sep 14, 2026MRTDIRX - Mail Petition Decision - Dismissed
Sep 3, 2026RXC/SRCertificate of Service
Sep 3, 2026MREXORX - Mail Ex Parte Request for Reexamination Granted
Aug 31, 2026RXPET.Receipt of Petition in a Reexam
Aug 28, 2026IDSCInformation Disclosure Statement considered
Aug 24, 2026MRILDRX - Mail Improper Letter Destroyed
Aug 11, 2026RXLET.Miscellaneous Incoming Letter
Aug 4, 2026RXPET.Receipt of Petition in a Reexam
Aug 4, 2026RXC/SRCertificate of Service
Jul 24, 2026RXC/SRCertificate of Service
Jul 16, 2026DOCKCase Docketed to Examiner in GAU
Jul 10, 2026MRXNReexamination Formalities Notice Mailed
Jul 10, 2026MRXNReexamination Formalities Notice Mailed
Jul 10, 2026COMPApplication Is Now Complete
Jul 9, 2026SMALApplicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27
Jul 9, 2026RXPCOMCompletion of Preprocessing - Released to Assigned GAU
Jul 9, 2026RXNREQFDNotice of reexamination request filing date
Jul 9, 2026RXNREQAUNotice of assignment of reexamination request
Jul 9, 2026FTFSFITF set to YES - revise initial setting
Jul 8, 2026RXTTLRPTTitle Report
Jul 1, 2026RXLITSRReexam Litigation Search Conducted
Jul 1, 2026PRXRParalegal Reexam Review Complete
Jun 26, 2026WIDSInformation Disclosure Statement (IDS) Filed
Jun 26, 2026WIDSInformation Disclosure Statement (IDS) Filed
Jun 26, 2026RXOSUB.RReexamination requested by third party requester
Jun 26, 2026RXOSUBReceipt of Original Ex Parte Reexam Request
Jun 26, 2026RXIDS.RReexam - Information Disclosure Statement Filed by Third Party Requester
Jun 26, 2026RXC/SRCertificate of Service
Jun 26, 2026RXAF/DRReexam - Affidavit(s), Declaration(s) and/or Exhibit(s) Filed by Third Party Requester
Jun 26, 2026BIG.Entity Status Set To Undiscounted (Initial Default Setting or Status Change)

Prosecution, PTAB & CAFC

PTAB Proceedings (IPR, PGR, CBM, DER)

None found

Federal Circuit (CAFC)

None found

Terminal Disclaimer

None found

Prosecution History

None found

Maintenance Fees

Grant
Mar 19, 2024
3.5-yr
Sep 19, 2027
7.5-yr
Sep 19, 2031
11.5-yr
Sep 19, 2035
Expiry
Feb 14, 2043

Entity Status

Large Entity

Expires

Feb 14, 2043 (16.6 yr remaining)

Assignments

Feb 2023Mar 2023FiledANNA GOPINEHUD MAROMSHAI RUBNOVMAPI PHARMA LTD.
AssignmentReel/Frame: 062686/0798Recorded: Feb 14, 2023

From

ANNA GOPINInventor
Feb 12, 2023
EHUD MAROMInventor
Feb 12, 2023
SHAI RUBNOVInventor
Feb 12, 2023
→

To

MAPI PHARMA LTD.